Blog

On the 11th of March 2022, a significant visit occurred at the Centre for Plant Medicine Research (CPMR) in Mampong-Akwapim, located in the Eastern Region of Ghana. A three-member delegation representing the European Union Mission (EUM) in Ghana and the European Investment Bank (EIB) made their way to the Centre, demonstrating the importance of international collaboration in advancing healthcare research and development.

The delegation comprised esteemed individuals: Madam Juliet Deku, Programme Manager (EUM); Madam Stefan Wunderlich, Diplomat Architect, Project Directorate; and Mr. Alessandra Badellino, Life Science Division, Project Directorate. Their visit held particular significance as it signaled a potential avenue for financial support towards infrastructure for Research & Development (R&D) activities at the CPMR, facilitated under the Ministry of Health (MoH) of Ghana.

During a meeting with the Management Committee of the CPMR, the delegation expressed their primary objective: to acquaint themselves with the operations and capabilities of the Centre in anticipation of extending financial assistance for infrastructure development. The discussion delved into the comprehensive activities and notable achievements of the CPMR, shedding light on its pivotal role in advancing herbal medicine research and healthcare provision in Ghana.

Subsequently, the delegation engaged in a guided tour of the CPMR facilities, providing them with firsthand insights into the Centre’s state-of-the-art laboratories, research units, and medicinal plant cultivation areas. This immersive experience allowed the visitors to gain a deeper understanding of the Centre’s research methodologies, innovative approaches, and potential areas for collaboration.

The visit by the European Union Mission and European Investment Bank underscored the global recognition of the Centre for Plant Medicine Research’s contributions to healthcare innovation. It also highlighted the significance of international partnerships in supporting the development of infrastructure and capabilities essential for advancing research and addressing healthcare challenges on a broader scale.